Huntsman (NYSE:HUN – Get Free Report) released its earnings results on Monday. The basic materials company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.18), Zacks reports. The company had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.45 billion. Huntsman had a negative return on equity of 0.03% and a negative net margin of 1.99%.
Huntsman Stock Performance
Shares of NYSE:HUN traded up $0.25 during trading on Wednesday, hitting $18.05. 637,457 shares of the stock traded hands, compared to its average volume of 2,807,796. The company has a quick ratio of 0.83, a current ratio of 1.47 and a debt-to-equity ratio of 0.45. The company has a fifty day moving average price of $17.52 and a two-hundred day moving average price of $20.19. Huntsman has a 52-week low of $15.67 and a 52-week high of $27.01. The company has a market cap of $3.12 billion, a price-to-earnings ratio of -26.14 and a beta of 0.95.
Huntsman Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Friday, March 14th will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 5.54%. Huntsman’s payout ratio is presently -144.93%.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on Huntsman
About Huntsman
Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.
Read More
- Five stocks we like better than Huntsman
- What is a support level?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- ESG Stocks, What Investors Should Know
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.